• 6681 Citations
  • 42 Scopus h-Index
1988 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Vivek Roy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 36 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
Dexamethasone Medicine & Life Sciences
Transplants Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Survival Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Thalidomide Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output 1988 2019

1 Citation (Scopus)

Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance

Kumar, S. K., Berdeja, J. G., Niesvizky, R., Lonial, S., Laubach, J. P., Hamadani, M., Stewart, A. K., Hari, P., Roy, V., Vescio, R., Kaufman, J. L., Berg, D., Liao, E., Rajkumar, S. V. & Richardson, P. G., Jan 1 2019, In : Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Maintenance
Stem Cell Transplantation
Disease-Free Survival

Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic Minorities

Ailawadhi, S., Azzouqa, A. G., Hodge, D., Cochuyt, J., Jani, P., Ahmed, S., Sher, T., Roy, V., Ailawadhi, M., Alegria, V. R., Manochakian, R., Vishnu, P., Grover, A., Abdulazeez, M. F., Paulus, A. & Chanan Khan, A. A., Jan 1 2019, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Survival
Survival Rate
Hispanic Americans
Epidemiology

Allogeneic hematopoietic cell transplant for relapsed-refractory, marginal zone lymphoma: a single-center experience

Dholaria, B. R., Hammond, W. A., Roy, V., Sher, T., Vishnu, P., Soyano, A., Finn, L. E. & Tun, H. W., Mar 23 2018, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-4 4 p.

Research output: Contribution to journalArticle

Lymphoma
Transplants
7 Citations (Scopus)
Primary Myelofibrosis
Hematopoietic Stem Cells
Karyotype
Transplants
Survival
5 Citations (Scopus)

Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis

Jain, T., Kunze, K. L., Temkit, M., Partain, D. K., Patnaik, M. M., Slack, J. L., Khera, N. D., Hogan, W., Roy, V., Noel, P., Leis, J. F., Sproat, L., Fauble, V., Mesa, R. A. & Palmer, J., May 24 2018, (Accepted/In press) In : Bone Marrow Transplantation. p. 1-8 8 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Hematopoietic Stem Cell Transplantation
Melphalan
Busulfan
Chimerism